Document:

Notice of Grant of Market Stock Units and 

        Market Stock Unit Award Agreement

         
	
        Hologic, Inc. 

        ID: 04-2902449

        35 Crosby Drive

        Bedford, MA 01730

 

 

  

	
        Grantee Name

        
	Plan: 2008 Equity Incentive 

Plan (the “Plan”)
	 	 

 

  

Effective
          , you (the “Grantee”) have been granted an award of           market stock units (“MSUs”) of Hologic, Inc. (the
“Company”). The MSUs are granted pursuant to the terms and conditions of
the Plan, referenced above, and the market stock unit award agreement (the “MSU Award Agreement”) provided
herewith.

 

Subject to the terms and conditions of the MSU Award Agreement
and the Plan, and achievement of the performance targets set forth in the 2012 Long-Term Performance Program (“2012 LTP Overview”),
the MSUs will vest on the third anniversary of the grant date (the “Restriction Lapse Date”), entitling you to receive
one share of the Company’s common stock for each MSU so vested.

 

By your signature and the Company's signature below, you and
the Company agree that these MSUs are granted under and governed by the terms and conditions of the Plan and the MSU Award Agreement.

 

 

 

	 	 	 	 
	Hologic, Inc.	 	Date	 
	 	 	 	 
	 	 	 	 
	Electronic Signature	 	Acceptance Date	 
	 	 	 	 

 

    	 

    	 

    

 

Hologic, Inc. 

Market Stock Unit Award Agreement

  

Market Stock Unit
Award Agreement (the “Award Agreement”) pursuant to the Hologic, Inc. 2008 Equity Incentive Plan, as it may be amended
from time to time (the “Plan”).

 

WITNESSETH:

 

WHEREAS, the Company
and the Grantee desire to enter into an agreement whereby the Company will grant the Grantee Market Stock Units (“MSUs”)
in respect of the Company’s Common Stock, $.01 par value per share (the “Common Stock”), as set forth in the
Notice of Grant of Market Stock Units to which this Award Agreement is attached (the “Award Notice”).

 

NOW THEREFORE, for
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and the Grantee agree
as follows:

 

1.          Grant
of MSUs. Pursuant to the terms and conditions of this Award Agreement and the Plan (which is incorporated herein by reference),
the Company hereby grants to the Grantee the number of MSUs as provided in the Award Notice. The shares of Common Stock covered
by these MSUs are sometimes hereinafter referred to as the “MSU Shares”.The number and class of securities and vesting
schedule of the MSUs are subject to adjustment as set forth in this Award Agreement, the Plan and the 2012 LTP Overview. In the
event of a conflict between the terms and conditions of the Plan and this Award Agreement, the terms and conditions of the Plan
shall prevail. Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Plan.

 

2.          Market
Stock Units. Each MSU entitles the Grantee to receive from the Company one share of Common Stock for each MSU Share vested
as of a Vesting Date (as defined below) in accordance with the terms of this Award Agreement and the Plan. As soon as practical
after a Vesting Date, the Company shall deliver the MSU Shares which have vested on that date.

 

3.          Vesting.
Subject to achievement of the performance targets set forth in the 2012 LTP Overview, the MSUs granted hereby will vest on
the earlier to occur of (i) the third anniversary of the Grant Date as provided in the Award Notice, or (ii) the termination
of the Grantee’s Service (as defined below) as a result of the death or Permanent Disability (as defined in Section
22(e)(3) of the Code) of the Grantee, provided that in each such case the Grantee has remained in continuous Service through
such date or termination, as applicable (the “Vesting Date”). The calculation of the number of MSUs that will
vest on the Vesting Date is based upon the price of the Company’s Common Stock, as specified in the 2012 LTP Overview,
which is incorporated in this document by reference. In the event and to the extent that any MSUs granted or otherwise
eligible to be issued hereunder do not vest on the Vesting Date, including the failure of the price of the Company’s
Common Stock to equal or exceed the threshold price of the Company’s Common Stock, in accordance with this Award
Agreement and the 2012 LTP Overview, then such MSUs shall be immediately forfeited. In the event and to the extent that the
threshold price of the Company’s Common Stock is exceeded based on the calculation described in the 2012 LTP Overview,
then an additional number of MSUs will vest as provided in the 2012 LTP Overview; provided, however, that in no event shall
the number of MSUs that vest on the Vesting Date exceed 200% of the number of MSUs granted under this Award Agreement without
regard to any adjustments provided by the 2012 LTP Overview. For purposes of this Agreement, the term “Service”
shall mean service as a Service Provider to the Company; and the term “Service Provider” shall mean an employee,
officer or director of the Company or an Affiliate of the Company or a consultant currently providing services to the Company
or an Affiliate of the Company. Whether a termination of Service shall have occurred for purposes of this Agreement shall be
determined by the Company, which determination shall be final, binding and conclusive. If the Grantee’s Service is
terminated prior to the Vesting Date, then the unvested MSUs shall terminate and Grantee shall have no further
rights hereunder.

 

4.          Nontransferability.
The MSUs granted pursuant to this Agreement may not be transferred without the consent of the Company, other than by will or
the laws of descent and distribution. 

 

    	 

    	 

    

 

5.          No
Rights Other Than Those Expressly Created. Neither this Award Agreement, the MSUs, nor any action taken hereunder shall
be construed as (i) giving the Grantee any right to be retained in the Service of, or continue to be affiliated with, the Company,
(ii) giving the Grantee any equity or interest of any kind in any assets of the Company, or (iii) creating a trust of any kind
or a fiduciary relationship of any kind between the Grantee and the Company. As to any claim for any unpaid amounts or distributions
under this Award Agreement, any person having a claim for payments shall be an unsecured creditor. The Grantee shall not have any
of the rights of a stockholder with respect to any MSU Shares until such time as the underlying MSU
has been vested and the MSU Shares have been issued.

 

6.          Compliance
with Laws. 

 

(a)          Withholding
of Taxes. Pursuant to applicable federal, state, local or foreign laws, the Company may be required to collect or withhold
income or other taxes from Grantee upon the Vesting Date or at some other time. The Company may require, upon the Vesting Date,
or demand, at such other time as it may consider appropriate, that the Grantee pay the Company the amount of any taxes which the
Company may determine is required to be collected or withheld, and the Grantee shall comply with the requirement or demand of the
Company.

 

(b)          Securities
Law Compliance. Upon vesting (or partial vesting) of the MSUs granted hereunder, the Grantee shall make such representations
and furnish such information as may, in the opinion of counsel for the Company, be appropriate to permit the Company to issue or
transfer the MSU Shares in compliance with the provisions of applicable federal or state securities laws. The Company, in its discretion,
may postpone the issuance and delivery of MSU Shares until completion of such registration or other qualification of such shares
under any federal or state laws, or stock exchange listing, as the Company may consider appropriate. In addition, the Company may
require that prior to the issuance or transfer of MSU Shares, the Grantee enter into a written agreement to comply with any restrictions
on subsequent disposition that the Company deems necessary or advisable under any applicable federal and state securities laws.
The MSU Shares issued hereunder may be legended to reflect such restrictions.

 

(c)          General.
No MSU Shares shall be issued upon vesting of an MSU granted hereunder unless and until the
Company is satisfied, in its sole discretion, that there has been compliance with all legal requirements applicable to the issuance
of such MSU Shares.

 

7.          Miscellaneous.

 

(a)          409A
Compliance. The Company may, in its sole and absolute discretion, delay payments hereunder or make such other modifications
with respect to the issuance of stock hereunder as it reasonably deems necessary to comply with Section 409A of the Code and interpretative
guidance thereunder.

 

(b)          Discretion
of the Committee. Unless otherwise explicitly provided herein, the Board of Directors of the Company, or an authorized committee
thereof, shall make all determinations required to be made hereunder, including determinations required to be made by the Company,
and shall interpret all provisions of this Award Agreement and the underlying MSUs, as it deems necessary or desirable, in its
sole and unfettered discretion. Such determinations and interpretations shall be binding on and conclusive to the Company and the
Grantee.

  

(c)          Amendment.
This Award Agreement may only be modified or amended by a writing signed by both parties.

 

(d)          Notices.
Any notices required to be given under this Award Agreement shall be sufficient if in writing and if sent by certified mail, return
receipt requested, and addressed as follows:

 

if to the Company:

 

Hologic, Inc.

35 Crosby Dr.

Bedford, MA 01730

Attention: Chief Financial Officer

 

    	 

    	 

    

 

if to the Grantee:

 

As set forth in the records of
the Company

 

or to such other address as either party may designate under
the provisions hereof.

 

(e)  
      Entire Agreement. This Award Agreement shall supersede in its entirety all prior
undertakings and agreements of the Company and Grantee, whether oral or written, with respect to the MSUs granted
hereunder; provided however that nothing herein shall supersede any prior written employment agreement, change of control
agreement or other similar written agreement (“Prior Agreement”), if any, that may provide, in certain
circumstances, for acceleration of vesting of equity awards granted to the Grantee. For the avoidance of doubt, the parties
hereby confirm that the MSUs granted hereunder shall be considered and treated restricted stock under any such Prior
Agreement for purposes of determining whether any such vesting is accelerated, and the amount of shares that vest pursuant to
this MSU shall be calculated as set forth in the 2012 LTP Overview.

 

(f)   
      Successors and Assigns. The rights and obligations of the Company under this Award
Agreement shall inure to the benefit of and be binding upon the successors and assigns of the Company.  

 

(g)    
    Applicable Law; Severability. All rights and obligations under this Award Agreement shall be
governed by the laws of the State of Delaware. In the event that any court of competent jurisdiction shall determine that any
provision, or any portion thereof, contained in this Award Agreement shall be unenforceable in any respect, then such
provision shall be deemed limited to the extent that such court deems it enforceable, and as so limited shall remain in full
force and effect. In the event that such court shall deem any such provision, or portion thereof, wholly unenforceable, the
remaining provisions of this Award Agreement shall nevertheless remain in full force and effect. 

 

(h)    
    Paragraph Headings; Rules of Construction. The paragraph headings used in this Award Agreement
are for convenience or reference, and are not to be construed as part of this Award Agreement. The parties hereto acknowledge
and agree that the rule of construction to the effect that any ambiguities are resolved against the drafting party shall not
be employed in the interpretation of this Award Agreement.

 

(i)    
     Electronic Copies. The Company may choose to deliver certain materials relating to the
Plan in electronic form. By accepting this Award Agreement, the Grantee consents and agrees that the Company may deliver the
Plan prospectus and the Company’s annual report to Grantee in an electronic format. If at any time Grantee would prefer
to receive paper copies of these documents, the Company will provide such copies upon request.

 

(j)     
    No Waiver of Rights, Powers and Remedies. No failure or delay by a party hereto in exercising
any right, power or remedy under this Agreement, and no course of dealing between the parties hereto, shall operate as a
waiver of any such right, power or remedy of the party, unless explicitly provided for herein. No single or partial exercise
of any right, power or remedy under this Award Agreement by a party hereto, nor any abandonment or discontinuance of steps to
enforce any such right, power or remedy, shall preclude such party from any other or further exercise thereof or the exercise
of any other right, power or remedy hereunder.

 

(k)  
      Counterparts. The Award Notice to which this Award Agreement is a part may be
executed in multiple counterparts, including by electronic or facsimile signature, each of which shall be deemed in original
but all of which together shall constitute one and the same instrument.FORM OF WARRANT

 

NEITHER THIS SECURITY
NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE
TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH
SECURITIES.

 

SERIES D COMMON STOCK PURCHASE WARRANT

 

ARMADA
OIL, INC.

	Warrant No. D-_000[·]	Issue Date: [·]
	Warrant Shares: [·]	Initial Exercise Date: [·]

 

THIS SERIES D COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, [·]
(the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after [·]
(the “Initial Exercise Date”) and on or prior to the close of business on [·]
(the “Termination Date”) but not thereafter, to subscribe for and purchase from Armada Oil, Inc., a
Nevada corporation (the “Company”)1, up to[·]
shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under
this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

THIS WARRANT IS BEING DELIVERED PURSUANT
TO THE TERMS OF THAT THAT CERTAIN SUBSCRIPTION AGREEMENT (THE “SUBSCRIPTION AGREEMENT”), BETWEEN THE COMPANY
AND THE SUBSCRIBER SIGNATORY THERETO.

 

Section 1.          Definitions.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in Subscription Agreement.

 

 

1 Three year term.

 

    	Appendix C 1

    	 

    

 

Section 2.          Exercise.

 

		a)	Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in
part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company
of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto (or such other office or agency of the Company
as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company);
and, within 3 Trading Days (as defined below) of the date said Notice of Exercise is delivered to the Company, the Company shall
have received payment of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier’s check
drawn on a United States bank. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant
has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within 3 Trading
Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number
of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall
deliver any objection to any Notice of Exercise Form within 2 Business Days following receipt of such notice. The Holder and
any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any
given time may be less than the amount stated on the face hereof. For purposes of this Agreement, the term “Trading
Day” means any day on which the New York Stock Exchange is open for business.

 

		b)	Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $1.25, subject
to adjustment hereunder (the “Exercise Price”).

 

		c)	Mechanics of Exercise.

 

		i.	Delivery of Certificates Upon Exercise.
Certificates for shares purchased hereunder shall be transmitted by the transfer agent of the Company to the Holder by physical
delivery to the address specified by the Holder in the Notice of Exercise within 3 Trading Days from the delivery to the Company
of the Notice of Exercise Form, surrender of this Warrant (if required) and payment of the aggregate Exercise Price as set forth
above (“Warrant Share Delivery Date”). This Warrant shall be deemed to have been exercised on the date the
Exercise Price is received by the Company. The Warrant Shares shall be deemed to have been issued, and Holder or any other person
so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the
date the Warrant has been exercised by payment to the Company of the Exercise Price and all taxes required to be paid by the Holder,
if any, pursuant to Section 2(e)(vi) prior to the issuance of such shares, have been paid.

 

		ii.	Delivery of New Warrants Upon Exercise. If
this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant
certificate, at the time of delivery of the certificate or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.

 

    	Appendix C 2

    	 

    

 

		iii.	Rescission Rights. If the Company fails to
cause its transfer agent to transmit to the Holder a certificate or certificates representing the Warrant Shares pursuant to Section
2(c)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

		iv.	No Fractional Shares or Scrip. No fractional
shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share
which Holder would otherwise be entitled to purchase upon such exercise, the Company shall at its election, either pay a cash
adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up
to the next whole share.

 

		v.	Charges, Taxes and Expenses. Issuance of
certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense
in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates
shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,
that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder; and the Company
may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.

 

		vi.	Closing of Books. The Company will not close
its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

Section 3.          Certain
Adjustments.

 

a)          Stock Dividends and Splits.
If the Company, at any time while this Warrant is outstanding: (A) pays a stock dividend or otherwise make a distribution or distributions
on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for
avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (B) subdivides
outstanding shares of Common Stock into a larger number of shares, (C) combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (D) issues by reclassification of shares of the Common Stock any shares
of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and
of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number
of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after
the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.

 

    	Appendix C 3

    	 

    

 

b)          Calculations.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

c)          Voluntary
Adjustment By Company. The Company may, in its sole discretion, at any time during the term of this Warrant extend the
term of the Warrant for up to an additional one year and reduce the then current Exercise Price, without in the sole discretion
of the Company increasing the number of shares issuable upon exercise of this Warrant, to any amount deemed appropriate by the
Board of Directors of the Company.

 

d)          Notice to Holder.

 

		i.	Adjustment to Exercise Price. Whenever the
Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly mail to the Holder a
notice setting forth the Exercise Price after such adjustment and setting forth a brief statement of the facts requiring such
adjustment.

 

		ii.	Notice to Allow Exercise by Holder. If (A)
the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock; (B) the Company shall declare
a special nonrecurring cash dividend on or a redemption of the Common Stock; (C) the Company shall authorize the granting to all
holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any
rights; (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common
Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets
of the Company, of any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property;
(E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company;
then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant
Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice
stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that
holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure
to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required
to be specified in such notice. The Holder is entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice.

 

    	Appendix C 4

    	 

    

 

Section 4.          Transfer
of Warrant.

 

a)          Transferability. Subject
to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions
of Section 2, of the Subscription Agreement, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder
or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or
assignees and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor
a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. A Warrant,
if properly assigned, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

b)          New Warrants. This
Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its
agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or
combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date set forth
above and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)          Warrant Register. The
Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant
as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes,
absent actual notice to the contrary.

 

d)          Transfer
Restrictions. If, at the time
of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be registered
pursuant to an effective registration statement under the Securities Act
and under applicable state securities or blue sky laws, the Company may require, as a
condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the transfer
provisions the Subscription Agreement.

 

    	Appendix C 5

    	 

    

 

Section 5.          Miscellaneous.

 

a)          No Rights as Shareholder Until
Exercise. This Warrant does not entitle the Holder to any voting rights or other rights as a shareholder of the Company
prior to the exercise hereof as set forth in Section 2(a).

 

b)          Loss, Theft, Destruction or
Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it
of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall
not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such
Warrant or stock certificate.

 

c)          Saturdays, Sundays, Holidays,
etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a business day, then such action may be taken or such right may be exercised on the next succeeding business day.

 

d)          Authorized Shares. 

The Company covenants that during the period
the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide
for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants
that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock
certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase rights under
this Warrant.

 

Except and to the extent as waived or consented
to by the Holder, the Company shall not by any action, including, without limitation, amending its articles of incorporation or
through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good
faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to
protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing,
the Company will (a) not increase the par value of any Warrant Shares above the amount payable therefore upon such exercise immediately
prior to such increase in par value, (b) take all such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (c) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction
thereof as may be necessary to enable the Company to perform its obligations under this Warrant.

 

    	Appendix C 6

    	 

    

 

Before taking any action which would result
in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall
obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body
or bodies having jurisdiction thereof.

 

a)          Jurisdiction. All questions
concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the
provisions of the Subscription Agreement.

 

b)          Restrictions. The Holder
acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions upon
resale imposed by state and federal securities laws.

 

c)          Non-waiver and Expenses.
No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of
such right or otherwise prejudice Holder’s rights, powers or remedies, notwithstanding the fact that all rights hereunder
terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to Holder such amounts as shall be sufficient to cover any
costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred
by Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

d)          Notices. Any notice,
request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance
with the notice provisions of the Subscription Agreement.

 

e)          Limitation of Liability.
No provision hereof, in the absence of any affirmative action by Holder to exercise this Warrant to purchase Warrant Shares, and
no enumeration herein of the rights or privileges of Holder, shall give rise to any liability of Holder for the purchase price
of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.

 

f)          Remedies.
Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to
specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert
the defense in any action for specific performance that a remedy at law would be adequate.

 

g)          Successors and Assigns.
Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit
of and be binding upon the successors of the Company and the successors and permitted assigns of Holder. The provisions of this
Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.

 

    	Appendix C 7

    	 

    

 

h)          Amendment. This Warrant
may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

i)          Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.

 

j)          Headings.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.

 

k)         Restricted Shares.
Holder understands and acknowledges that the Warrant Shares
have not been registered under the 1933 Act for resale and Holder
will not sell, offer to sell, assign, pledge, hypothecate or otherwise transfer any of the Warrant Shares
unless pursuant to an effective registration statement under the 1933 Act, or unless an exemption from registration is available.
Notwithstanding anything to the contrary contained in this Warrant, Holder may transfer (without
restriction and without the need for an opinion of counsel) the Warrant Shares to its Affiliates
(as defined below) provided that each such Affiliate is an “accredited investor” under Regulation D and such Affiliate
agrees to be bound by the terms and conditions of the Subscription Agreement. For the purposes of this Warrant, an “Affiliate”
of any person or entity means any other person or entity directly or indirectly controlling, controlled by or under direct or indirect
common control with such person or entity.

 

IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

	ARMADA OIL, INC.
	 
	By:	 
	Name:	 
	Title:	 

 

    	Appendix C 8

    	 

    

 

NOTICE OF EXERCISE

(Series D Warrant)

 

		To:	Armada Oil, Inc.

10777 Westheimer, Suite 1100

Houston, Texas 77042

 

(1)                  The
undersigned hereby elects to purchase ______________Warrant Shares of the Company pursuant to the terms of the attached Series
D Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable
transfer taxes, if any.

 

(2)                  Please
issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is
specified below:

 

_______________________________

 

_______________________________

 

_______________________________

 

_______________________________

 

(3)         Accredited
Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities
Act of 1933, as amended.

 

________________________________________________________________________

Signature of Holder

 

________________________________________________________________________

Name of Investing Entity

 

________________________________________________________________________

Signature of Authorized Signatory of Investing Entity

 

_________________________________________________

Name of Authorized Signatory

 

___________________________________________________________________

Title of Authorized Signatory:

 

____________________

Date

 

    	1

    	 

    

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute
this form and supply required information.

Do not use this form to exercise the warrant.)

 

		TO:	Armada Oil, Inc.

10777 Westheimer, Suite 1100

Houston, Texas 77042

 

FOR VALUE RECEIVED, [___________] all of
or [____________] shares of the foregoing Series D Warrant of Armada Oil, Inc. and all rights evidenced thereby are hereby assigned
to

 

_______________________________________________ whose address
is

 

_______________________________________________________________.

 

_______________________________________________________________

 

Dated: _____________, 20___

 

	Holder’s Signature:	 
	 	 
	Holder’s Address:	 
	 	 
	 	 

 

Signature Guaranteed: ___________________________________________

 

NOTE: The signature to this Assignment Form must correspond
with the name as it appears on the face of the Series D Common Stock Purchase Warrant, without alteration or enlargement or any
change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary
or other representative capacity should file proper evidence of authority to assign the foregoing Series D Common Stock Purchase
Warrant.

 

    	1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}]]